hVIVO

FY2025 results

  • Apr 15 2026, 07:10 IST/BST
  • Colin Grant
  • Company Report
  • 7 page(s)
  • Sectors : Pharma and healthcare
  • Companies : hVIVO

Ratings and price correct at time of issue.

  • hVIVO

    Closing Price: 8.7p

  • RATING 11/10/23

  • PREVIOUS RATING 17/02/20

    UNDER REVIEW

Person's Name

Colin Grant

Analyst

DAVY VIEW

hVIVO has reported FY2025 results that are in line with the figures given in its January trading statement as well as our forecasts. Revenues declined due to order cancellations. However, the company was EBITDA positive and has a healthy balance sheet, and there is now cautious optimism regarding the outlook.

View full article

Download full report with analyst certification and important disclosures

Apr 15 2026, 07:10 IST/BST

Download